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Proper folding of proteins (either newly synthesized or
damaged in response to a stressful event) occurs in a
highly regulated fashion. Cytosolic chaperones such as
Hsc/Hsp70 are assisted by cofactors that modulate the
folding machinery in a positive or negative manner. CHIP
(carboxyl terminus of Hsc70-interacting protein) is such a
cofactor that interacts with Hsc70 and, in general, atten-
uates its most well characterized functions. In addition,
CHIP accelerates ubiquitin-dependent degradation of
chaperone substrates. Using an in vitro ubiquitylation
assay with recombinant proteins, we demonstrate that
CHIP possesses intrinsic E3 ubiquitin ligase activity and
promotes ubiquitylation. This activity is dependent on
the carboxyl-terminal U-box. CHIP interacts functionally
and physically with the stress-responsive ubiquitin-
conjugating enzyme family UBCH5. Surprisingly, a major
target of the ubiquitin ligase activity of CHIP is Hsc70
itself. CHIP ubiquitylates Hsc70, primarily with short,
noncanonical multiubiquitin chains but has no apprecia-
ble effect on steady-state levels or half-life of this protein.
This effect may have heretofore unanticipated conse-
quences with regard to the chaperoning activities of
Hsc70 or its ability to deliver substrates to the protea-
some. These studies demonstrate that CHIP is a bona fide
ubiquitin ligase and indicate that U-box-containing pro-
teins may comprise a new family of E3s.
Multifunctionality is a common feature of highly conserved
eukaryotic proteins and often becomes evident when these
proteins are analyzed in dissimilar species and in different
cellular systems. The cytosolic heat shock proteins Hsp90 and
Hsc/Hsp70 are one such set of proteins. Heat shock proteins
have evolved as chaperones to catalyze the proper folding of
nascent proteins but have accrued additional functions that
include renaturation of proteins damaged under stressful con-
ditions, targeting proteins for degradation, participation in cel-
lular signaling events, and regulation of developmental pro-
cesses (1). Similarly, the discovery that ubiquitylation of
nascent proteins can occur co-translationally suggests that the
ubiquitin-proteasome system initially evolved as an error-
checking system to mark improperly or unnecessarily synthe-
sized proteins for destruction (2). This same system is now
recognized to assist in the timely destruction of mature pro-
teins once their functions are no longer needed.
A coordinated interaction between the ubiquitin-proteasome
and chaperone systems is indicated by the observations that a
significant proportion of newly synthesized proteins are either
chaperone-associated (3) or rapidly degraded via the ubiquitin-
proteasome pathway (4). Manipulations of the chaperone system
can alter the balance between folding and degradation of chap-
erone substrates (5), suggesting that substrate interactions with
chaperones (and consequently their commitment either toward
the folding pathway or to their degradation via the ubiquitin-
proteasome machinery) serve as an essential post-translational
protein quality control mechanism within eukaryotic cells. The
partitioning of proteins to either one of these mutually exclusive
pathways is referred to as “protein triage” (6).
It is well accepted that chaperones play a central role in the
triage decision (7–9); however, less well understood are the
events that lead to the cessation of efforts to fold a substrate
and the removal of the substrate to the terminal degradative
pathway. It is possible that chaperones and components of the
ubiquitin-proteasome pathway exist in a state of competition
for these substrates and that repeated cycling of a substrate on
and off a chaperone maintains the substrate in a soluble state
and increases, in a stochastic fashion, its likelihood of interac-
tions with the ubiquitin machinery (6). However, some data
argue for a more direct role for the chaperones in the degrada-
tion process (10). Plausible hypotheses to explain these obser-
vations include direct associations between the chaperone and
ubiquitin-proteasome machinery to facilitate transfer of a sub-
strate from one pathway to the other or conversion of the
chaperone itself to a ubiquitylation complex (11). It is also
entirely possible that several quality control pathways may
exist and that the endogenous triage decision may involve
components of each of these hypotheses.
Our laboratory has recently reported the cloning and char-
acterization of CHIP (carboxyl terminus of Hsc70-interacting
protein) (12), a tetratricopeptide repeat (TPR)1-containing pro-
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tein that inhibits Hsc/Hsp70 ATPase activity, substrate bind-
ing, and refolding activities without affecting substrate release.
These in vitro properties imply that CHIP inhibits at least
some of the properties of Hsc/Hsp70 that are required for their
chaperoning activities. CHIP also interacts with and remodels
Hsp90 heterocomplexes in a manner that is antagonistic to
proper substrate chaperoning activity (13). Remarkably, CHIP
is able to target the immature form of the Hsc70 substrate
cystic fibrosis transmembrane conductance regulator for deg-
radation (14); likewise, the glucocorticoid receptor, a model
substrate of the Hsp90 chaperone machinery, is diverted to-
ward the degradative pathway by CHIP (13). These data place
CHIP at the crux of the protein triage decision and indicate
that resolving the question of how CHIP diverts proteins to the
degradative pathway may provide some of the clues necessary
to decide how quality control is regulated for chaperone
substrates.
The processes of ubiquitylation, transport to the proteasome,
and proteolysis are regulated by a surprisingly complex series
of events (reviewed in Ref. 2). Proteins to be ubiquitylated must
be recognized by the ubiquitylation machinery via some signal
(often misfolding or a phosphorylation event). Ubiquitin that
has been activated by E1 is transferred to an E2 ubiquitin-
conjugating enzyme. In contrast with the single E1 enzyme,
multiple E2 enzymes exist, and each is involved in the degra-
dation of a limited number of proteins that often share similar
functions. E2s associate directly or indirectly with specific E3
ubiquitin ligases, which in turn recognize specific substrates to
facilitate the transfer of activated ubiquitin to one or more
lysine residues in the substrate. Once a single ubiquitin resi-
due is added to a target protein, multiubiquitin chains rapidly
form, usually by isopeptide bonds involving the lysine 48 resi-
due of ubiquitin. These multiubiquitin chains are sufficient to
target the substrate to the 26 S proteasome, where their de-
ubiquitylation, unfolding, and degradation occur (15).
The effects of CHIP on glucocorticoid receptor and cystic
fibrosis transmembrane conductance regulator degradation
(13, 14) indicate that it is likely to play a role in the aforemen-
tioned ubiquitylation machinery, although the precise role
played by CHIP and the additional factors it interacts with
remain to be determined. Amino acid sequence analysis of
CHIP identified, in addition to the amino terminus tetratri-
copeptide repeats, a carboxyl-terminal domain with similarity
to UFD2, a yeast protein to which multiubiquitin chain elon-
gation activity (an “E4” activity) has been attributed (16). Mod-
eling studies suggest that this carboxyl-terminal domain,
called the U-box, forms a structure similar to that of a RING
finger (17). Since the presence of RING finger domains is now
known to typify a growing group of ubiquitin ligases, it is
reasonable to speculate that U-box-containing proteins such as
CHIP may serve a similar function. In this report, we test this
hypothesis and show that one target for CHIP-mediated ubiq-
uitylation is Hsc70. U-box-containing proteins may constitute a
new class of ubiquitin ligases, and proteins like CHIP may play
a role in regulating the stress response via its ubiquitylation
activity.
MATERIALS AND METHODS
Antibodies—The following antibodies were used for immunoblotting:
mouse anti-HA (Roche Molecular Biochemicals), mouse anti-ubiquitin
(Babco), mouse anti-His (Novagen), mouse anti-Hsc70/Hsp70 (Stress-
Gen), and rabbit anti-CHIP (12). Mouse anti-Hsc70/Hsp70 and mouse
anti-Myc antibody-agarose conjugates (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) were used for immunoprecipitations.
Transient Transfections—COS-7 cells were transiently transfected
using FuGene according to the protocol of the manufacturer (Roche
Molecular Biochemicals). pcDNA3-CHIP, pcDNA3-CHIP H260A,
pcDNA3-CHIP TPR (amino acid residues 32–145 deleted), and
pcDNA3-CHIP U-box (residues 196–303 deleted) were transfected
with vectors expressing HA- and Myc-tagged ubiquitin (generous gifts
of Ron Kopito, Stanford University). In some experiments, transfected
cells were treated with MG-132 (25 M) or vehicle for 2.5 h or were
subjected to heat shock at 42 °C before harvesting.
Western Blotting and Immunoprecipitations—Transfected cells were
harvested 48 h after transfection and lysed with radioimmune precip-
itation buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EGTA, 0.25%
sodium deoxycholate, 1% Nonidet P-40, 1 mM Na3VO4) supplemented
with protease inhibitors and 50 mM N-ethylmaleimide. Cell lysates
were clarified by centrifugation at 16,000  g for 10 min, and protein
concentration was determined. For immunoprecipitations, equal
amounts of lysate proteins were incubated with 10–15 l/mg mouse
monoclonal antibody-agarose conjugates at 4 °C for 2 h. The beads were
washed five times with lysis buffer. Immunoprecipitated proteins or cell
lysates were mixed with 3 SDS sample buffer and were separated by
SDS-PAGE. Western blotting was performed as described (12) with the
appropriate antibodies.
Protein Purification—CHIP, CHIP-H260A, and CHIP U-box, as
well as the E2 ubiquitin-conjugating enzymes UBCH5a, UBCH5b,
UBCH5c, E2-20k, UBCH7, UBC3, and E2-25k, were expressed as His-
tagged fusion proteins in Escherichia coli BL21 (DE3) cells using vector
pET-30a as previously described (12). E2 expression plasmids were a
kind gift of Kazuhiro Iwai (Kyoto University). Expression of recombi-
nant proteins was induced with 1 mM isopropyl-1-thio--D-galactopyr-
anoside for 3 h at 37 °C. Cells were lysed by sonication. His-tagged
proteins were purified by Ni2 chelation chromatography. The relative
ubiquitin-conjugating activities of E2 enzymes were determined by
their abilities to form thiolester adducts with ubiquitin according to the
method of Pickart and Vella (18).
In Vitro Ubiquitylation Reactions—Bacterially expressed CHIP,
CHIP-H260A, and CHIP U-box and/or Hsc70 was incubated in the
presence of 4 M CHIP or CHIP mutants, 0.1 M purified rabbit E1
(Calbiochem), 2.5 mg/ml ubiquitin (Sigma) or His-tagged ubiquitin (Cal-
biochem), and equivalent activities of E2 enzyme in 20 mM MOPS, pH
7.2, 100 mM KCl, 5 mM MgCl2, 5 mM ATP, 10 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride for 4 h at 30 °C. Samples were analyzed
by SDS-PAGE and immunoblotting performed with appropriate
antibodies.
S-protein Pull-down Assays—Bacterially expressed S-tagged CHIP
and His-tagged E2 were incubated for 1 h at 4 °C in 1 ml of binding
buffer (20 mM Tris (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.1%
Triton X-100, 25 g/ml bovine serum albumin), and then incubated with
10 l of S-protein-agarose (Novagen) for 30 min at room temperature.
Precipitates were washed three times with binding buffer and subjected
to 12% SDS-PAGE and immunoblotting with anti-His antibody.
Pulse-Chase Experiments—Transiently transfected COS-7 cells were
preincubated in a methionine-free, cysteine-free medium and then met-
abolically labeled with 50 Ci/ml [35S]methionine for 20 min
(PerkinElmer Life Sciences) and chased at different time points. Myc-
Hsc70 was immunoprecipitated with mouse anti-Myc antibody and
identified by SDS-PAGE, followed by autoradiography.
Mutagenesis—A point mutation of histidine to alanine at position of
260 of CHIP was generated by the QuikChangeTM XL site-directed
mutagenesis kit (Stratagene) with mutagenic primers 5-CGCAAGGA-
CATCGAGGAGGCCCTGCAGCGTGTGGG-3 and 5-CCCACACGCT-
GCAGGGCCTCCTCGATGTCCTTGCG-3 to create the plasmid CHIP-
H260A. Point mutations were also created in HA-tagged ubiquitin to
convert lysines 29, 48, and 63 to arginine (singly and in combination) by
similar methods.
RESULTS
CHIP Functions as a U-box-dependent E3 Ubiquitin Ligase—
Having previously demonstrated that CHIP elicited the ubiq-
uitylation and proteasome-mediated degradation of ectopically
expressed glucocorticoid receptor, a model chaperone substrate
(13), we wanted to determine whether expression of CHIP
affected the ubiquitylation of endogenous proteins. We overex-
pressed CHIP in COS cells with a hemagglutinin-tagged ubiq-
uitin (HA-Ub), in the absence or presence of MG-132, a selec-
tive inhibitor of proteasome activity. A slowly migrating smear
of high molecular weight proteins detectable by Western blot-
ting for the HA epitope was enhanced in cells overexpressing
CHIP, and the accumulation of these species was accentuated
in the presence of the proteasome inhibitor (Fig. 1). We can
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conclude that these high molecular weight species represent
proteins ubiquitylated with HA-tagged ubiquitin in the pres-
ence of CHIP, because these high molecular weight species
were not detected in cells treated similarly but transfected with
a Myc-tagged ubiquitin instead of HA-Ub. These experiments
indicate that CHIP can serve as a ubiquitylation factor for
endogenous proteins; moreover, CHIP appears to be a rate-
limiting factor for these ubiquitylation events.
We reconstituted ubiquitylation reactions with recombinant
proteins to determine how CHIP participated in ubiquitylation.
We used an approach similar to that used to characterize the
ubiquitin ligase activity of the RING finger protein c-Cbl, in
which ubiquitylation in the absence of a specific substrate is
tested as an indication of multiubiquitin chain assembly that
occurs either freely, on co-purifying proteins, or on the ubiq-
uitin ligase itself (19). Bacterially expressed CHIP and
UBCH5a, an E2 ubiquitin-conjugating enzyme, were incubated
in a reaction containing ubiquitin and E1, and these reaction
mixtures were probed by Western blotting with an anti-ubiq-
uitin antibody. Ubiquitylation activity, as assessed by the de-
tection of high molecular weight multiubiquitin chains, was
only detected in reactions containing E1, UBCH5a, and CHIP
in the presence of ubiquitin (Fig. 2A). Thus, CHIP is sufficient
to serve as a ubiquitin ligase in these reconstitution experi-
ments. Because the U-box of CHIP is predicted to have a
modified RING finger-like structure, we determined whether
the U-box (contained in the carboxyl-terminal residues 196–
303) was necessary for this ubiquitin ligase activity by perform-
ing similar reactions with a protein lacking this motif. In com-
parison with full-length CHIP, the truncated protein lacking
the U-box had no ubiquitin ligase activity (Fig. 2B). We also
found that BAG-1, which is also a chaperone cofactor that
contains a ubiquitin-like domain at its amino terminus and
participates in interactions between Hsc70 and the proteasome
(20), could not replace CHIP in these reactions. In addition,
identical results demonstrating the ubiquitin ligase activity of
CHIP were obtained in similar in vitro reconstitution assays
using a ubiquitin-glutathione S-transferase fusion as an arti-
ficial substrate for ubiquitylation (data not shown). Thus,
CHIP has all of the characteristics of a ubiquitin ligase, and
this activity is U-box-dependent.
The UBCH5 Ubiquitin-conjugating Enzyme Family Interacts
Functionally with CHIP—Ubiquitin ligases interact function-
ally with specific E2 ubiquitin-conjugating enzymes to facili-
tate substrate recognition and ubiquitin transfer (21). We
tested the ability of CHIP to assemble multiubiquitin chains in
the presence of a panel of ubiquitin-conjugating enzymes. We
found that the three mammalian members of the UBCH5 fam-
ily (UBCH5a, -b, and -c) were able to interact functionally with
CHIP in the ubiquitylation process (Fig. 3A). E2-20k, UBCH7,
UBC3, and E2-25k were ineffective in facilitating CHIP-medi-
ated multiubiquitin chain assembly. The UBCH5 E2 enzymes
are structurally very similar to one another (22) and are closely
related structurally to the yeast E2 enzymes UBC4 and UBC5,
which are stress-activated ubiquitin-conjugating enzymes that
preferentially mediate degradation of short lived and damaged
proteins (23). Based on the functional cooperativity observed
between CHIP and UBCH5 proteins, we tested whether these
proteins directly interacted, since physical E2-E3 interactions
are thought to determine substrate specificity for ubiquityla-
tion (24). Indeed, we found in co-precipitation experiments that
recombinant CHIP and UBCH5a are physically associated with
one another under conditions that efficiently promote ubiqui-
tylation in vitro (Fig. 3B).
CHIP Is Autoubiquitylated in Vitro—In the course of the
ubiquitylation reactions, we noted the presence of discrete
slowly migrating complexes when immunoblotting for CHIP
(brackets in Figs. 2 and 3). These bands were present only when
reactions were performed in the presence of E1, E2, CHIP, and
ubiquitin (Fig. 2A) and did not occur in reactions containing the
FIG. 1. CHIP increases ubiquitylation of proteins in vivo.
COS-7 cells were transiently transfected with HA-Ub or Myc-Ub with or
without CHIP and treated with 25 M MG-132 for 2.5 h as indicated.
HA-Ub conjugates were separated by SDS-PAGE, and Western blotting
(WB) was performed with an anti-HA antibody. Cell lysates were blot-
ted simultaneously with anti-CHIP and anti--actin antibodies (lower
panels). MW, molecular weight; NS, nonspecific.
FIG. 2. CHIP is an E3 ubiquitin ligase, and the U-box of CHIP
is required for its E3 ligase activity. A, in vitro ubiquitylation
reactions were performed with purified Ub, E1, the E2 UBCH5a, and
CHIP as indicated. Following SDS-PAGE, blots were probed with anti-
ubiquitin and anti-CHIP antibodies, as indicated. B, in vitro ubiquity-
lation reactions were performed with purified ubiquitin, E1, and E2
UBCH5a. CHIP, a fragment of CHIP lacking the U-box motif (U-box),
or BAG-1 was used in the reactions, as indicated. Ubiquitin conjugates
were resolved by SDS-PAGE and detected by anti-ubiquitin or anti-
CHIP antibodies. Brackets denote slowly migrating modified forms of
CHIP.
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U-box-deleted form of CHIP (Fig. 2B). Together, these findings
suggested to us that CHIP undergoes autoubiquitylation. To
ascertain that this is indeed the case, we compared the molec-
ular weights of these complexes when ubiquitylation reactions
were performed with ubiquitin or with a polyhistidine-tagged
Ub. The modified forms of CHIP migrated more slowly in
reactions containing His-Ub, indicating that they reflect mul-
tiubiquitin-modified CHIP (data not shown). Autoubiquityla-
tion has been described for other E3 ligases (25, 26) and may
provide a means of autoregulation of ubiquitin ligase activity.
Hsc70 Is an Endogenous Target for CHIP-mediated Ubiqui-
tylation—Based on several lines of reason, we considered
whether Hsc70 itself was a target for ubiquitylation mediated
by CHIP. First, Hsc70 is a functional interaction partner with
CHIP (12, 14). Second, we noted that the most prominent
ubiquitin-conjugated proteins detected when CHIP is overex-
pressed appear at 80 kDa and above (Figs. 1 and 4A), which
would be consistent with these bands representing ubiquitin-
modified forms of Hsc70. However, until now ubiquitin-medi-
ated modification of the cytosolic chaperones has not been
described. Therefore, to test this possibility, we examined ubiq-
uitylation of endogenous Hsc70 in COS cells transfected with
CHIP or empty vector. First, we asked whether ubiquitylated
proteins were present in Hsc70 immunoprecipitates. Ubiquity-
lated proteins (detected by HA blotting) were only present in
immunoprecipitates of COS cells co-transfected with CHIP
(Fig. 4A). Surprisingly, blotting of Hsc70 immunoprecipitates
with Hsc70 demonstrated that at least some of these bands
were ubiquitin-Hsc70 conjugates (Fig. 4B). The bands disap-
peared when immunoprecipitates were treated with ubiquitin-
carboxyl hydrolase, indicating that these higher bands did in-
deed contain ubiquitin (not shown). These retarded bands did
not represent substrates bound to Hsc70, since they did not
release when immunoprecipitates were incubated with ATP
(Fig. 4B). We also could demonstrate that this effect was inde-
pendent of overexpression of HA-Ub, since Hsc70 could be
modified as efficiently in cells only expressing endogenous
ubiquitin (Fig. 4C).
CHIP contains TPR domains at its amino terminus and the
U-box domain at its carboxyl terminus. To determine the re-
quirements of each of these domains in these ubiquitylation
effects, we created CHIP expression vectors lacking the TPR
(TPR) or U-box (U-box) domains. These truncated proteins
were expressed in levels equivalent to wild-type CHIP when
transfected in COS cells (not shown). In contrast with the
wild-type protein, neither of the truncated proteins induced
ubiquitylation of Hsc70 (Fig. 4D). Thus, the effect of CHIP on
Hsc70 is specific and requires both the Hsc70-binding domain
and the U-box domain. The total amount of ubiquitylated
Hsc70 was estimated in COS cells expressing endogenous lev-
els of CHIP and in cells overexpressing CHIP. Approximately
1% of Hsc70 was ubiquitylated under endogenous conditions
(primarily in the monoubiquitylated form, although additional
modifications could be observed on overexposure of blots), and
11% of Hsc70 was ubiquitylated when CHIP was overexpressed
(data not shown). Although only a minor fraction of Hsc70 is
ubiquitylated under standard conditions, this still represents a
large amount of protein, since Hsc70 accounts for 1% of all
proteins within COS cells.
If CHIP indeed ubiquitylates Hsc70 via its E3 ubiquitin
ligase activity, then we should be able to recapitulate this
ubiquitylation reaction in a reconstituted reaction with puri-
fied proteins. To test this, reactions with or without recombi-
nant E1, E2 (UBCH5a), and CHIP were used to assess for
ubiquitin modification of Hsc70. Ubiquitylation of Hsc70 was
observed in these in vitro reactions and only occurred in the
presence of ubiquitin, E1, E2 (UBCH5a), and CHIP (Fig. 5A).
Consistent with our previous observations of multiubiquitin
chain assembly, the U-box domain of CHIP was required for
this activity. Replacement of ubiquitin by N-methylated ubiq-
uitin blocked formation of all but the singly modified forms of
Hsc70, indicating that Hsc70 is ubiquitylated at a single site by
CHIP. In addition, we found that CHIP-mediated ubiquityla-
tion of Hsc70 required members of the UBCH5 family of ubiq-
uitin-conjugating enzymes (Fig. 5B). Taken together with the
data in Fig. 4, these experiments demonstrate that Hsc70 is a
target for ubiquitylation and that CHIP functions as a ubiq-
uitin ligase to catalyze this reaction in vitro and in vivo.
Ubiquitylation of Hsc70 has, to our knowledge, not been
described previously and immediately raises several questions
as to the cellular consequences of such an event (see discussion
below). Previously, we have shown that chaperone substrates
targeted for ubiquitylation by CHIP are rapidly degraded in
vivo (13, 14). However, we did not observe decreases in steady-
state levels of Hsc70 when CHIP is overexpressed (for example,
see Fig. 4). To test the stability of Hsc70 in the presence of
increased levels of CHIP, we co-transfected CHIP with an
amino-terminal Myc-tagged Hsc70 expression plasmid (so we
could measure the effects on Hsc70 only in transfected cells),
and pulse-labeled the cells with [35S]methionine, followed by
immunoprecipitation. (In preliminary experiments, we found
that Myc-tagging had no effect on the ability of Hsc70 to inter-
act with CHIP.) In COS cells overexpressing CHIP, we detected
labeled bands that corresponded to the ubiquitylated forms of
Hsc70 (arrow, Fig. 6). However, the stability of Hsc70 was not
significantly affected by CHIP-induced ubiquitylation. Al-
though we cannot exclude the possibility that a small (and, in
FIG. 3. UBCH5 family members couple with CHIP in its ligase
reactions. A, in vitro ubiquitylation reactions were performed with
ubiquitin, E1, CHIP, and equivalent activities of different E2 ubiquitin-
conjugating enzymes, as indicated. Ubiquitin conjugates and CHIP
were detected with respective antibodies. B, recombinant CHIP (con-
taining an S-tag) and His-tagged UBCH5a were co-incubated, and the
association between S-tagged CHIP and His-tagged UBCH5a was
measured using an S-protein pull-down assay. UBCH5a was detected
with an anti-His antibody.
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these analyses, unmeasurable) proportion of Hsc70 is suscep-
tible to degradation after ubiquitylation by CHIP, the stability
of the ubiquitin-modified forms of Hsc70 in this assay argues
that the ubiquitylation of Hsc70 induced by CHIP (in contrast
with the activity of CHIP on glucocorticoid receptor and cystic
fibrosis transmembrane conductance regulator) is not suffi-
cient to target Hsc70 for degradation and may instead have
other effects on Hsc70 function.
Because Hsc70 plays a role in protection against thermal and
other types of stress, we asked whether the ubiquitylation of
Hsc70 by CHIP was modified under conditions of thermal
stress. Although the levels of Hsc70 were increased after heat
shock, this had no effect on the amount of ubiquitylated Hsc70
that accumulated (Fig. 7A). We also tested the ubiquitin link-
ages that are used to assembly multiubiquitin chains on Hsc70,
reasoning that the short length of the chains and their failure
to signal degradation of Hsc70 may indicate that the ubiquitin-
ubiquitin bonds are forming via residues other than lysine 48;
in particular, we tested the importance of lysines 29 and 63,
given existing evidence that linkages via these residues serve
functions other than signaling degradation (27). We found that
mutation of lysine 48 to arginine did not decrease the ubiqui-
tylation of Hsc70 and in fact enhanced this effect (Fig. 7B).
Likewise, single mutations of lysine 29 or 63 did not prevent
Hsc70 ubiquitylation. However, when both lysines 29 and 63
were mutated together, with or without mutation of lysine 48,
only a single ubiquitin residue was added to Hsc70, and mon-
oubiquitylation of Hsc70 under these circumstances was either
relatively unstable, possibly because it is a better target for
deubiquitylating enzymes, or conjugated inefficiently. Taken
together, these studies argue that Hsc70 is normally ubiquity-
lated by CHIP via noncanonical ubiquitin chains that utilize
either lysine 29 or 63 of ubiquitin and that do not target Hsc70
for proteasome-mediated degradation.
Evidence for Mechanistic Differences between U-box and
RING Finger E3 Activities—RING fingers contain conserved
cysteine residues that coordinate Zn2 ions to stabilize the
structure of the motif as well as a conserved aromatic residue
(such as Trp408 in Cbl) that participates in E2 activation and
ubiquitylation (17, 19). This residue of the RING finger directly
interacts with the cognate E2 enzyme and probably determines
E3-E2 selectivity (28), and its mutation invariably abolishes
ubiquitin ligase activity of proteins containing RING fingers
(19). Proteins predicted to contain U-boxes also contain a con-
served aromatic residue (usually tryptophan or histidine) at
this position (17); in the case of CHIP, the corresponding resi-
due is a histidine at position 260. We mutated this residue to
alanine in order to determine whether the conserved aromatic
residue of U-box-containing proteins served a role similar to
the analogous amino acid in RING fingers. However, in con-
trast to expectations derived from mutagenesis of RING finger
domains, we found that ubiquitylated species in general, and
ubiquitylated forms of Hsc70 in particular, accumulated in
COS cells expressing the H260A mutant with efficiency almost
equal to that of cells expressing the wild-type protein (Fig. 8A).
Similarly, when recombinant proteins were tested in an in vitro
reconstitution assay, we found that the H260A mutant, al-
though not as active as the wild-type protein, still possessed
considerable ubiquitin ligase activity when compared with
CHIP lacking the U-box (Fig. 8B). These results indicate that
the U-box motif, while also serving a ubiquitin ligase function,
may mediate interactions with ubiquitin-conjugating enzymes
and facilitate ubiquitylation events through mechanisms dif-
ferent from those that occur with RING finger-containing ubiq-
uitin ligases.
FIG. 4. CHIP stimulates ubiquityla-
tion of Hsc70. A, COS-7 cells were tran-
siently transfected with HA-Ub with or
without CHIP and treated with 25 M
MG-132 for 2.5 h before harvesting. Ly-
sates were immunoprecipitated with anti-
Hsc70 antibody. Lysates and immunopre-
cipitated proteins were immunoblotted
for HA. B, COS-7 cells were transfected
and immunoprecipitated as in A, except
that some cells were harvested and incu-
bated for 30 min in radioimmune precip-
itation buffer containing 2.5 mM ATP, as
indicated. Immunoprecipitated proteins
were immunoblotted for Hsc70. C, COS-7
cells were transiently transfected with or
without CHIP and HA-Ub as indicated
and immunoprecipitated and immuno-
blotted as in B. D, COS-7 cells were tran-
siently transfected with CHIP or its mu-
tants as indicated. Cell lysates were
immunoblotted for Hsc70.
FIG. 5. A, CHIP acts as an E3 ligase for Hsc70, and the U-box of CHIP
is required for its E3 ligase activity. In vitro ubiquitylation reactions
were performed as in Fig. 2 except that 2 M purified Hsc70 was
included in the reactions. Me-Ub, methyl-ubiquitin. B, UBCH5 family
members couple with CHIP in its ligase activity for Hsc70. In vitro
ubiquitylation reactions were performed as in Fig. 3A except that 2 M
purified Hsc70 was included in the reactions. Ubiquitin conjugates of
Hsc70 were resolved by SDS-PAGE and detected with an anti-Hsc70
antibody.
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DISCUSSION
Previous studies have linked U-box-containing proteins with
ubiquitylation (13, 14, 16, 29). In this report, we demonstrate
through several lines of evidence that the U-box protein CHIP is
a bona fide ubiquitin ligase that regulates ubiquitylation activity
in vitro and in vivo via interactions with the UBCH5 family of
ubiquitin-conjugating enzymes. To date, two additional U-box-
containing proteins have been characterized. NOSA is a develop-
mentally regulated protein found in Dictyostelium that affects
the ubiquitylation of a subset of proteins in this species (29). The
means by which NOSA exerts its activities are not certain, but it
seems likely that this protein is also a ubiquitin ligase. A mul-
tiubiquitin chain extension activity (or E4 activity) was attrib-
uted to a second U-box-containing protein, UFD2 (16). Based on
our observations, we would predict that the E4 activity is similar
or identical in some respects to ubiquitin ligase activity; studies
to test whether UFD2 directly interacts with E2 enzymes and
elicits ubiquitin chain extension in an E2-dependent manner will
be helpful in addressing this issue. Nonetheless, it is reasonable
to hypothesize that many, if not most, proteins containing U-
boxes will be ubiquitin ligases, and therefore that the U-box
family will form a new family of ubiquitin ligases similar to the
RING finger and HECT domain families (30).
We found that CHIP interacts functionally with the UBCH5
family of ubiquitin-conjugating enzymes. The association of
CHIP with this family of E2 enzymes may be instructive with
regard to the cellular role of CHIP, insofar as the related S.
cerevisiae proteins, UBC4 and UBC5, are up-regulated in re-
sponse to stress and are protective against stress-mediated
injury (23, 31). In addition, UBC4 and UBC5 are required for
the selective degradation of short lived and abnormal proteins
(23).IthaspreviouslybeenpostulatedthatUBC4/UBC5/UBCH5-
dependent proteolysis is mechanistically linked with the func-
tion of molecular chaperones such as Hsc70 (23). The experi-
ments presented here support this hypothesis and indicate that
interactions with CHIP are at least one means by which this
linkage occurs. Based on these studies and our previous reports
indicating thatCHIPtargets chaperonesubstrates forubiquitin-
dependent degradation (13, 14), we propose that CHIP, via its
ubiquitin ligase activity as well as its ability to interact with
and modify the function of the stress-induced molecular chap-
erones (12, 13), participates in the stress response by partition-
ing chaperone substrates (which may, under endogenous con-
ditions, be proteins that have been damaged under harsh
conditions) toward the stress-associated degradative pathway.
We have previously shown that model chaperone substrates
glucocorticoid receptor and cystic fibrosis transmembrane con-
ductance regulator are ubiquitylated and degraded by a CHIP-
dependent pathway (13, 14). It is therefore quite surprising
that a major endogenous target of CHIP-mediated ubiquityla-
tion is Hsc70 itself. One possible reason for this activity is that
CHIP targets Hsc70 for ubiquitin-dependent degradation. This
does not seem to be the case, however, since steady-state levels
of Hsc70, as well as its half-life, are not affected by CHIP
overexpression (Figs. 5 and 7) (findings that stand in contrast
with our previous observations that overexpression of CHIP
FIG. 6. CHIP does not decrease the half-life of Hsc70. COS-7 cells were transiently transfected with Myc-Hsc70 with or without CHIP. Cells
were pulse-labeled with [35S]methionine and chased at different time points, as indicated. Myc-Hsc70 was immunoprecipitated and detected by
autoradiography. Results shown are representative of three independent experiments.
FIG. 7. Factors affecting modification of Hsc70 by CHIP. A,
COS-7 cells overexpressing CHIP, as indicated, were subjected to heat
shock at 42 °C for the indicated times. Cell lysates were immunopre-
cipitated and blotted with an antibody to Hsc70 to determine the effects
of heat shock on CHIP-mediated Hsc70 ubiquitylation. B, COS-7 cells
were transiently transfected with CHIP, as indicated, and with he-
magglutinin-tagged wild-type (WT) Ub or with HA-ubiquitin containing
mutations of lysine to the indicated arginine (R) residues. Immunopre-
cipitation was performed with an anti-Hsc70 antibody, followed by
immunoblotting with an anti-hemagglutinin antibody to detect ubiqui-
tylated species of Hsc70.
FIG. 8. CHIP H260A does not abolish the effects of CHIP as an
E3 ligase. A, COS-7 cells were transiently transfected with wild type or
mutant CHIP with HA-Ub or Myc-Ub. Some cells were treated with 25
M MG-132 for 2.5 h, as indicated. Cell lysates were immunoblotted
with anti-HA antibody (upper panel). The blot was stripped and re-
probed with anti-Hsc70 antibody (lower panel). B, in vitro ubiquityla-
tion reactions were performed as in Fig. 2 except that wild type or
mutant CHIP was used. Multiubiquitylation chain assembly was de-
tected as in Fig. 2.
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decreases steady-state levels of chaperone substrates (13, 14)).
We cannot exclude entirely the possibility that Hsc70 is being
targeted for degradation by CHIP, since it is conceivable that
only a small population of Hsc70 molecules are available for
ubiquitin-dependent degradation; however, the stability of
ubiquitylated forms of Hsc70 detected in our pulse-chase ex-
periments would again argue against this interpretation. A
second possible explanation for these observations is that
Hsc70 is being ubiquitylated artifactually; although such an
interpretation would not discount the attribution of ubiquitin
ligase activity to CHIP, we think it unlikely insofar as this
effect can be observed in two independent assays (in vitro and
in vivo) and does not happen to other abundantly expressed
proteins such as -actin (Fig. 1).
Several aspects of CHIP-mediated Hsc70 ubiquitylation
events are atypical and may therefore provide clues to the
functional role of this activity. First, these ubiquitylated forms
are readily observed even in the absence of proteasome inhibi-
tion (in contrast to ubiquitin conjugates of chaperone sub-
strates that are elicited by CHIP (13)), suggesting that they are
not recognized as a degradation signal by the proteasome.
Second, the major ubiquitylated forms of Hsc70 detected in our
assays have relatively short ubiquitin chains (less than four).
In general, it is thought that once ubiquitylation begins, mul-
tiple ubiquitin residues are added rapidly, so our observations
would be contrary to this dogma (32). It is conceivable that the
predominance of short chains is due to steric changes in Hsc70
that interfere with its recognition by antibodies; this would not,
however, explain the stability of these ubiquitin conjugates.
Another, more intriguing possibility is that shorter multiubiq-
uitin chains, perhaps involving atypical (other than lysine 48-
linked) chains, are being formed on Hsc70 and that these
chains do not serve as recognition signals for the proteasome
but somehow alter the function of Hsc70, serve as a targeting
sequence, or otherwise alter cellular signaling events. Recent
studies indicate that noncanonical ubiquitin linkages (involv-
ing lysine 29 and lysine 63) do occur. Rather than serving as
degradation markers, these linkages mediate signaling events
(particularly under conditions of cellular stress) and partici-
pate in replicative DNA repair, endocytosis of plasma mem-
brane proteins, and ribosomal function (27, 31, 33–37). Inter-
estingly, the yeast homologues of the UBCH5 family, UBC4
and UBC5, are the E2s implicated in catalyzing noncanonical
ubiquitin linkage formation in yeast (31). Because lysines 29 or
63 of ubiquitin are required for Hsc70 ubiquitylation by CHIP,
we can infer that Hsc70 is indeed ubiquitylated in a noncanoni-
cal fashion, which may provide important clues to the cellular
role of ubiquitylated Hsc70.
If ubiquitylation of Hsc70 is not targeting this chaperone for
degradation but is instead serving another purpose, what
might that be? Several possibilities can be considered. Ubiqui-
tylation may target a portion of Hsc70 molecules to a particular
subcellular location, as is the case for uracil permease (36).
Another possibility is that ubiquitin modification may alter the
ATPase activity of Hsc70 or its affinity for substrates, either of
which would affect its activity as a chaperone in ways that may
be relevant in the context of protein triage decisions that are
being affected by CHIP. Last, it is possible that ubiquitin
modification serves to target Hsc70 to the proteasome, yet due
to the nature of the ubiquitin linkages formed (or for other
reasons), Hsc70 is resistant to proteasome-mediated degrada-
tion. Such a scenario has interesting implications, since Hsc70
has recently been linked physically to the proteasome via in-
termediary interactions with BAG-1 (20), and we have previ-
ously shown that CHIP links Hsc70 functionally with the pro-
teasome (13, 14). Several proteins, including BAG-1 itself and
the hPLIC ubiquitylation factors, contain ubiquitin-like do-
mains that are thought to facilitate interactions between these
proteins and the proteasome, although these ubiquitin-like
domain-containing proteins themselves are not thought to be
substrates for proteasome-mediated degradation (20, 38). It is
conceivable that short ubiquitin chains serve a similar purpose
when attached to Hsc70 and provide an additional means by
which CHIP links the chaperone and proteasome machinery.
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